Podcasts about pharmaceutical

Last night's Pacers game was rough to watch, Is the US about to go on a bombing run on Iran? Maneuvers in the Middle East, Is the US bringing the bunker buster with them? Trump smacking down Macron, It's a scam! Trump wants blue cities targeted for deportation first, IBJ calls for Hogsett's resignation. States agree to $7.4 billion settlement with Purdue Pharma in opioid litigation, Trump wants an end not a ceasefire, Get Your Happy Meal Purse, They should have done the deal. The Iranians need to topple the Ayatollah. IBJ calls for Hogsett resignation. Welcome to the party IBJ, Pharmaceutical company planning to relocate from California to Fishers, Le Peep rebrands to Maple, Nearly 1 million illegal immigrants have 'self deported' under Trump, Big Beautiful Bill riding on SALT, Rokita first state AG to threaten private colleges over DEI, echoing Trump with Harvard, Time to end the Ayatollah regime See omnystudio.com/listener for privacy information.

IBJ calls for Hogsett resignation. Welcome to the party IBJ, Pharmaceutical company planning to relocate from California to Fishers, Le Peep rebrands to Maple, Nearly 1 million illegal immigrants have 'self deported' under Trump, Big Beautiful Bill riding on SALT, Rokita first state AG to threaten private colleges over DEI, echoing Trump with Harvard, Time to end the Ayatollah regimeSee omnystudio.com/listener for privacy information.

Join me, Charles River's Miriam Guest, and independent consultant Vanessa Figueroa as we tackle the role of a microbiologist in drug manufacturing. Who is keeping patients safe from contamination, and how are they making sure our life saving drugs are not contaminated? How is manufacturing like yoga? Find out by listening now!

Ian Bremmer, president of the Eurasia Group, joins "CBS Mornings" to break down a weekend of deep division in the U.S., as millions protested President Trump and his military parade, and deadly new strikes between Iran and Israel raised fears of a wider regional war in the Middle East. The jury in Karen Read's retrial began deliberations Friday afternoon and will continue Monday. Read is facing three charges in the 2022 death of her police officer boyfriend, John O'Keefe, including second-degree murder. Her first trial ended with a hung jury. Pharmaceutical giant Eli Lilly announced a price cut for its drug, Zepbound, for people who aren't using insurance. CBS News' Nancy Chen reports on the qualifications for the discount and what the cost reduction will be. Artificial intelligence is being used to create realistic video and audio to impersonate people, in some cases looking for love or deceiving companies looking to hire. In a 2024 study, half of the businesses surveyed said they'd experienced AI deepfake fraud. CBS News MoneyWatch correspondent Kelly O'Grady reports. In this week's "Beg-Knows America," CBS News contributor David Begnaud revisits the life-changing world of high school speech and debate, an activity that shaped his own path. He meets the inspiring young voices featured in the new documentary "SPEAK," tackling grief, identity, and advocacy with extraordinary courage. Consumer Reports' deputy editor Brian Vines joins "CBS Mornings" to share the latest sunscreen testing results, including top-rated picks and expert tips to keep you and your family safe in the sun this summer. To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices

睽違半年Happy Hour總算更新啦！這次若晴跟Angel來聊聊最近剛從研討會回來的一些見聞和心得，非常適合搭配上一集新手村005一起收聽！當然我們也不忘Happy Hour的慣例，跟大家分享了一則近期非常振奮人心的客製化基因療法突破的新聞。等待Happy Hour已久的聽眾趕緊收聽吧！ 節目內容： 跟大家更新一下近況 客製化基因療法大突破 芝加哥三腳貓4/6小聚 AACR開幕式小花絮 跟同事學了poster session的搜集資訊的招數 小廢物拿好拿滿還有免費專業大頭照 NIH fellowship小會議見聞 會議結識新朋友的喜悅 -- Hosting provided by SoundOn

Tara Brown and Laura Sparkes discuss the shameful mid-20th-century practice of forcing unwed mothers to give up their child for adoption, then being made to take carcinogenic drugs to dry up their breast milk.See omnystudio.com/listener for privacy information.

Aaron Alt, CFO at Cardinal Health (CAH), joins Diane King Hall at the NYSE set to discuss the company's financial outlook. He describes the drugmaker's share buyback plans and recent FY25 guidance raise. Alt says the company's recent strategic acquisitions help broaden the company's healthcare reach, including glucose monitoring for diabetes treatment.======== Schwab Network ========Empowering every investor and trader, every market day.Subscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribeDownload the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7Watch on Sling - https://watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watchWatch on Vizio - https://www.vizio.com/en/watchfreeplus-exploreWatch on DistroTV - https://www.distro.tv/live/schwab-network/Follow us on X – https://twitter.com/schwabnetworkFollow us on Facebook – https://www.facebook.com/schwabnetworkFollow us on LinkedIn - https://www.linkedin.com/company/schwab-network/About Schwab Network - https://schwabnetwork.com/about

Marta Wosinska, PhD, and Joey Mattingly, PharmD, MBA, PhD, joined Over the Counter to discuss the potential impact pharmaceutical tariffs may have on pharmacies if they are to be widely implemented in the near future.

During this episode, Santosh is joined by Joel Wayment, VP and GM of 3PL logistics at Cardinal Health. Joel provides an in-depth exploration of pharmaceutical cold chain logistics, highlighting the critical evolution of medical product transportation. He discusses how emerging technologies, sustainability efforts, and innovative packaging solutions are transforming the supply chain, particularly for ultra-sensitive medical products like cell and gene therapies. Joel also emphasizes the importance of minimizing product touches, leveraging AI and data insights, and creating environmentally friendly shipping solutions. Key takeaways include the role of technology in improving supply chain visibility, the impact of disruptions like COVID-19 on logistics innovation, the ongoing challenge of getting critical medical products safely and efficiently from manufacturers to patients, and so much more. Highlights from their conversation include:Cardinal Health Overview (1:10)Joel's Background and Journey (1:58)Evolution of Cold Chain Logistics (2:49)Advancements in Packaging Solutions (4:43)Visibility and Transparency in Shipping (5:40)Patient-Centric Approaches (7:30)Monitoring Product Conditions (9:20)Sustainability in Packaging (11:14)Consolidation and Optimization Strategies (14:52)Lessons from Supply Chain Disruptions (16:41)Balancing Regulation and Flexibility (19:40)Data Insights for Accountability (21:46)The Role of AI in Logistics (24:45)Proactive Decision-Making with Data (26:54)Final Thoughts and Takeaways (28:13)Dynamo is a VC firm led by supply chain and mobility specialists that focus on seed-stage, enterprise startups.Find out more at: https://www.dynamo.vc/

Section 232 comments on pharmaceutical and semiconductor investigations are available for review. Listen for more on Two Minutes in Trade. 

What if I told you that everything we believed about vaccine safety was built on manipulated data that pharmaceutical companies never wanted us to see? In this interview, I sat down with Dr. Aseem Malhotra, renowned British cardiologist, who reveals how independent analysis of Pfizer's original trial data showed you were more likely to suffer serious harm from the vaccine than be hospitalized with COVID at a rate of 1 in 800. Dr. Malhotra walks me through his co-founded Hope Accord petition signed by tens of thousands of medical professionals calling for a moratorium, how politicians were systematically misled, and why trust in medicine has plummeted to historic lows. Join my FREE 3-Day Ultimate Detox Challenge starting June 23rd.: ⁠https://bit.ly/3ZgCW4u⁠ Join the Ultimate Human VIP community today!: ⁠https://bit.ly/4ai0Xwg⁠ Connect with Dr. Aseem Malhotra: Website: ⁠https://bit.ly/4dCGKRZ⁠  YouTube: ⁠https://bit.ly/4jKLGal⁠  Instagram: ⁠https://bit.ly/4dFY2gY⁠  Facebook:⁠https://bit.ly/48ghD6F⁠  TikTok: ⁠https://bit.ly/4eZyHjr⁠  X.com: ⁠https://bit.ly/4eXnL5O⁠  Thank you to our partners: H2TABS - USE CODE “ULTIMATE10” FOR 10% OFF: ⁠https://bit.ly/4hMNdgg⁠ BODYHEALTH - USE CODE “ULTIMATE20” FOR 20% OFF: ⁠http://bit.ly/4e5IjsV⁠ BAJA GOLD - USE CODE "ULTIMATE10" FOR 10% OFF: ⁠https://bit.ly/3WSBqUa⁠ EIGHT SLEEP - SAVE $350 ON THE POD 4 ULTRA WITH CODE “GARY”: ⁠https://bit.ly/3WkLd6E⁠ COLD LIFE - THE ULTIMATE HUMAN PLUNGE: ⁠https://bit.ly/4eULUKp⁠ WHOOP - GET 1 FREE MONTH WHEN YOU JOIN!: ⁠https://bit.ly/3VQ0nzW⁠ MASA CHIPS - GET 20% OFF YOUR FIRST ORDER: ⁠https://bit.ly/40LVY4y⁠ VANDY - USE CODE “ULTIMATE20” FOR 20% OFF: ⁠https://bit.ly/49Qr7WE⁠ AION - USE CODE “ULTIMATE10” FOR 10% OFF: ⁠https://bit.ly/4h6KHAD⁠ HAPBEE - FEEL BETTER & PERFORM AT YOUR BEST: ⁠https://bit.ly/4a6glfo⁠ CARAWAY - USE CODE “ULTIMATE” FOR 10% OFF: ⁠https://bit.ly/3Q1VmkC⁠ HEALF - GET 10% OFF YOUR ORDER: ⁠https://bit.ly/41HJg6S⁠ BIOPTIMIZERS - USE CODE “ULTIMATE” FOR 10% OFF: ⁠https://bit.ly/4inFfd7⁠ RHO NUTRITION - USE CODE “ULTIMATE15” FOR 15% OFF: ⁠https://bit.ly/44fFza0⁠ GENETIC TEST: ⁠⁠https://bit.ly/3Yg1Uk9⁠ Connect with Gary Brecka: Instagram: ⁠https://bit.ly/3RPpnFs⁠ TikTok: ⁠https://bit.ly/4coJ8fo⁠ YouTube: ⁠⁠https://bit.ly/3RPQYX8⁠ X.com: ⁠https://bit.ly/3Opc8tf⁠ Facebook: ⁠https://bit.ly/464VA1H⁠ Website: ⁠https://bit.ly/4eLDbdU⁠ Merch: ⁠https://bit.ly/4aBpOM1⁠ Newsletter: ⁠https://bit.ly/47ejrws⁠ Timestamps: 00:00 ​Intro of Show 02:55 COVID-19 Vaccine Moratorium Petition Discussion 07:10 Historical vaccine withdrawals (swine flu, rotavirus) 09:40 COVID-19 Vaccine Moratorium Petition Current Status 20:11 Call for medical establishment apology & acknowledgment 24:52 Pharmaceutical manipulation vs. political misleading 29:31 Psychological barriers to accepting uncomfortable truths 34:19 Individual methylation differences and spike protein clearance 36:07 The realizations of the COVID propaganda campaigns 41:09 Treatment protocols for vaccine-injured patients 45:35 Framingham Study revelations 55:44 Dr. Malhotra's clinical approach to cholesterol management 01:00:15 Inflammation as root cause vs. cholesterol theory 01:09:16 Dr. Malhotra opinion on public health policy 01:17:48 ​What does it mean to you to be an Ultimate Human? The Ultimate Human with Gary Brecka Podcast is for general informational purposes only and does not constitute the practice of medicine, nursing or other professional health care services, including the giving of medical advice, and no doctor/patient relationship is formed. The use of information on this podcast or materials linked from this podcast is at the user's own risk. The Content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Users should not disregard or delay in obtaining medical advice for any medical condition they may have and should seek the assistance of their health care professionals for any such conditions. Learn more about your ad choices. Visit megaphone.fm/adchoices

Today is day two of our special anniversary series + we are welcoming Melissa Ward back to the show! This conversation is from February of 2024, and was one of my favorite episodes! Melissa and I talked about her career in the pharmaceutical industry, how she started blogging, how to always be growing, and not get stuck in your ways. Melissa is a mom who lives in North Carolina with her husband and two kids. Armed with a degree in Fashion and Textile Management from NC State University, Melissa's career journey took an unexpected turn when she went to work for start-up pharmaceutical companies for over 10 years following graduation.In 2020 Melissa begin her own small business journey part-time. Fueled by her passion for finding deals on items for home, style, and kids, she decided to start her own blog and Instagram account, @preppygoods.Before long, Melissa took the plunge to full-time content creation, transforming her love for discovering budget-friendly hidden-gems into a career. Her curated content revolves around showcasing finds from major retailers like Amazon, Walmart, and Target, as well as highlighting lesser-known treasures from small businesses.Whether you're into home decor, fashion inspiration, or kid-friendly goodies, Melissa has you covered. You can explore her curated picks for preppy grandmillennials on her website, www.preppygoods.com, or connect with her on social media platforms such as Instagram, TikTok, and Pinterest, all under the handle @preppygoods. Y'all are going to love my episode with Melissa!Melissa's WebsiteMelissa's InstagramSarah's Smile

About this episode: Would it be a good idea to have tariffs on pharmaceuticals? In this episode: a conversation about the rationales for tariffs as well as potential downsides—like higher drug prices—and what could really help with supply and pricing issues. Guest: Dr. Mariana Socal studies the pharmaceutical market and is an associate professor in Health Policy and Management at the Johns Hopkins Bloomberg School of Public Health. Host: Dr. Josh Sharfstein is vice dean for public health practice and community engagement at the Johns Hopkins Bloomberg School of Public Health, a faculty member in health policy, a pediatrician, and former secretary of Maryland's Health Department. Show links and related content: Tariffs as a Hidden Tax: Price Pass-Through in Multi-Stage Supply Chains—Johns Hopkins Carey Business School Trump's pharmaceutical tariffs could raise costs for patients, worsen drug shortages—NBC Los Angeles Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

Our guest on this week's episode is Michael Needham, principal procurement & supply chain at Efficio Consulting. Among the flurry of executive orders issued recently by the White House is one aimed at restoring pharmaceutical manufacturing capabilities here in the U.S. Currently most drugs and ingredients are manufactured in China and India. How will such a move affect supply chains? Our guest offers his views on what can be manufactured here easily and what could be more difficult.Measuring the health of our supply chains, the Logistics Manager's Index came out on Tuesday, showing an expansion in logistics activity in May. Logistics expanded for the second straight month, marked by a mix of slowing inventory levels and rising costs across the board, researchers said. We look at the specific numbers and what they mean.This week we saw a study on workplace injuries. This report came from the Travelers Companies. It found that the number of workplace injuries overall continues to decline, although the costs associated with them are climbing. We dive into some of the details of the report and how emphasizing safety can affect the workplace. Supply Chain Xchange  also offers a podcast series called Supply Chain in the Fast Lane.  It is co-produced with the Council of Supply Chain Management Professionals. All episodes are available to stream now. Go to your favorite podcast platform to subscribe and to listen to past and future episodes. The podcast is also available at www.thescxchange.com.Articles and resources mentioned in this episode:OfficioMay 2025 Logistics Managers' IndexWorkplace injury rate drops, but costs riseVisit Supply Chain XchangeListen to CSCMP and Supply Chain Xchange's Supply Chain in the Fast Lane podcastSend feedback about this podcast to podcast@agilebme.comPodcast is sponsored by: Storage SolutionsOther linksAbout DC VELOCITYSubscribe to DC VELOCITYSign up for our FREE newslettersAdvertise with DC VELOCITY

Here in Episode #37, podcast host Dr. Jerry Workman speaks with Dr. Austin Daniels, application scientist for Yokogawa Fluid Imaging Technologies. This Episode will focus on flow imaging microscopy (FIM), a new technology for subvisible particle characterization in biologics. We have invited Austin to our Analytically Speaking podcast to discuss the current trends and state of using FIM to ensure the quality and safety of biologics. This requires precise monitoring of subvisible particles, which can impact drug efficacy and patient health. Traditional analysis methods, such as light obscuration (LO) and membrane microscopy (MM), provide limited data on particle types and morphology, making it difficult to pinpoint contamination sources.

Send us a textA critique of SSRIs and pharma's influence on medicine, including SSRI-induced sexual dysfunction, suicidality, and violence. Long Summary: Dr. David Healy critiques modern medicine, focusing on SSRIs and psychiatric medicine, including: how pharmaceutical companies manipulate clinical trial data, ghostwrite studies, and influence medical practice, often ignoring patient experiences; highlighting issues like post-SSRI sexual dysfunction (PSSD), the immediate sensory effects of SSRIs, and their potential to induce suicidal or violent behavior; challenging the reliance on randomized controlled trials (RCTs) over individual patient reports; and more.About the guest: David Healy, MD, PhD, a psychiatrist and pharmacologist, has decades of experience researching the serotonin system and SSRIs, working across Ireland, the UK, Canada, and the US. He is a professor at McMaster University and a vocal critic of pharmaceutical industry practices.Discussion Points:SSRIs cause near-immediate sensory effects, like genital numbing, in most people.Post-SSRI sexual dysfunction (PSSD) can persist for years or decades after stopping the drug, affecting many long-term users.Healy argues RCTs prioritize averages over individual experiences, often missing serious side effects like suicidality.Pharmaceutical companies ghostwrite studies and manipulate data, with journals like the New England Journal of Medicine publishing misleading articles.Serotonin theory of depression lacks evidence.Industry tactics include dismissing patient reports as anecdotes and using high doses in trials to mask weak efficacy.SSRIs can increase suicide risk, not just during initiation but also when adjusting doses or withdrawing, as seen in cases like the Aurora movie theater shooting.Regulatory bodies like the FDA often fail to investigate adverse effects due to bureaucratic processes and lack of follow-up.Healy emphasizes doctors' failure to prioritize patient observations, driven by industry-influenced standards of care.Related episode:M&M 88: Depression, Serotonin, SSRIs, Psychiatry & Social Media | Joanna Moncrieff*Not medical advice.Support the showAll episodes, show notes, transcripts, and more at the M&M Substack Affiliates: KetoCitra—Ketone body BHB + potassium, calcium & magnesium, formulated with kidney health in mind. Use code MIND20 for 20% off any subscription (cancel anytime) Lumen device to optimize your metabolism for weight loss or athletic performance. Code MIND for 10% off Readwise: Organize and share what you read. 60 days FREE through link SiPhox Health—Affordable at-home blood testing. Key health markers, visualized & explained. Code TRIKOMES for a 20% discount. MASA Chips—delicious tortilla chips made from organic corn & grass-fed beef tallow. No seed oils or artificial ingredients. Code MIND for 20% off For all the ways you can support my efforts

Gemma started her career studying Mechanical Engineering at Cardiff University. She quickly discovered the world of Continuous Improvement and spent 20 years working to improve processes and systems within various manufacturing industries including Automotive, Pharmaceutical, Dairy, Cosmetics & Toiletries, Food, and Medical Devices. She has been a CI Manager numerous times and an Operations Manager running a factory of over 500 people.Gemma is hugely passionate about Improvement and developing people and processes. She gets such a kick out of coaching and facilitating, especially when she sees the lightbulb switch on in someone's head – when they solve a problem; when they realize they have the power to change; or when they get excited about all the improvements they could make.In 2019, Gemma left the world of employment to establish her own business, SPARK Improvement, aiming to switch on as many lightbulbs as possible. Her mission is to help organizations and individuals be the BEST they can be, by helping people SEE, helping people THINK, and helping people CHANGE.Gemma is based in Cheshire in the UK, working globally.Link to claim CME credit: https://www.surveymonkey.com/r/3DXCFW3CME credit is available for up to 3 years after the stated release dateContact CEOD@bmhcc.org if you have any questions about claiming credit.

Tune in as Glenn Hunzinger, PwC's Health Industries Leader, and Phil Scalfani, PwC's Pharmaceutical and Life Sciences Consulting Leader, discuss the Trump administration's executive order on Most Favored Nation (MFN) drug pricing and its far-reaching implications across the healthcare ecosystem. They break down what MFN pricing could mean for pharmaceutical companies, payers, PBMs, and the broader drug supply chain, and share perspectives on how organizations can navigate the uncertainty ahead.  Discussion Highlights: The MFN executive order is a bold attempt to lower U.S. drug prices by benchmarking them against the lowest prices paid in other high-income countriesPharma companies may be forced to rethink global pricing strategies, balancing U.S. price cuts with potential increases or market exits abroadA proposed shift to direct-to-consumer drug access could disrupt traditional roles for pharmacies, distributors, and pharmacy benefit managers (PBMs)Companies are preparing for significant uncertainty by reassessing deals, modeling financial impacts, and closely monitoring upcoming rulemaking and potential legal developmentsSpeakers:Glenn Hunzinger, Health Industries Leader, PwCPhilip Sclafani, Partner, Pharma & Life Sciences, PwCLinked materials:Most Favored Nation prescription drug pricing Executive OrderFor more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.

We welcome Karla Childers to AI Uncovered. Karla is a long-standing leader in bioethics and data transparency in the pharmaceutical industry. As part of the Office of the Chief Medical Officer at Johnson & Johnson, she brings deep expertise in navigating the ethical implications of emerging technologies, especially artificial intelligence, in medicine and drug development.In this episode, Tim and Karla explore the intersection of AI, bioethics and patient-centered development. They discuss how existing ethical frameworks are being challenged by the rise of generative AI and why maintaining human oversight is critical—especially in high-context areas like clinical trial design, consent and medical communications. Karla also shares her views on the future of data privacy, the complexity of patient agency and how to avoid losing trust in the race for efficiency.Karla is a strong advocate for using innovation responsibly. From her work with internal bioethics committees to her perspective on evolving regulatory expectations, she offers bold insights into how the industry can modernize without compromising ethics or equity.Welcome to AI Uncovered, a podcast for technology enthusiasts that explores the intersection of generative AI, machine learning, and innovation across regulated industries. With the AI software market projected to reach $14 trillion by 2030, each episode features compelling conversations with an innovator exploring the impact of generative AI, LLMs, and other rapidly evolving technologies across their organization. Hosted by Executive VP of Product at Yseop, Tim Martin leads a global team and uses his expertise to manage the wonderful world of product.

Listen in as our expert panel discusses medications for the treatment of Alzheimer dementia.  They'll review the risks and benefits of cholinesterase inhibitors, memantine, and the anti-amyloid monoclonal antibodies.  And you'll hear strategies for managing behavioral and psychological symptoms of dementia.   Special guests:Tatyana Gurvich, PharmD, BCGP, APhAssociate Professor of Clinical PharmacyMann USC School of PharmacyUCI Senior Health CenterCandace Pierce, DNP, RN, CNE, COINurse Educator, Nurse Planner, and Healthcare LeaderColibri HealthcareDarlene Moyer, MD, FAAFPAssociate Director, HonorHealth Family Medicine Residency ProgramAssociate Professor of Clinical Practice – SOMME – Arizona State UniversityClinical Associate Professor – University of Arizona College of Medicine - PhoenixYou'll also hear practical advice from panelists on TRC's Editorial Advisory Board:Stephen Carek, MD, CAQSM, DipABLMClinical Associate Professor of Family MedicinePrisma Health/USC-SOMG Family Medicine Residency ProgramUSC School of Medicine GreenvilleCraig D. Williams, PharmD, FNLA, BCPSClinical Professor of Pharmacy PracticeOregon Health and Science UniversityNone of the speakers have anything to disclose. This podcast is an excerpt from one of TRC's monthly live CE webinars, the full webinar originally aired in April 2025.TRC Healthcare offers CE credit for this podcast. Log in to your Pharmacist's Letter, Pharmacy Technician's Letter,or Prescriber Insights account and look for the title of this podcast in the list of available CE courses.Claim CreditThe clinical resources mentioned during the podcast are part of a subscription to Pharmacist's Letter, Pharmacy Technician's Letter, and Prescriber Insights: FAQ - Alzheimer Dementia Pharmacotherapy Chart – Pharmacotherapy of Dementia BehaviorsChart - Drugs with Anticholinergic ActivityChart - Send us a textCheck out our NEW podcasts.Rumor vs TruthYour trusted source for facts... where we dissect the evidence behind risky rumors and reveal clinical truths.Clinical CapsulesTRC editors break down the most impactful clinical developments - giving you clear, actionable takeaways in just minutes.If you're not yet a subscriber, find out more about our product offerings at trchealthcare.com. Follow, rate, and review this show in your favorite podcast app. Find the show on YouTube by searching for ‘TRC Healthcare' or clicking here. You can also reach out to provide feedback or make suggestions by emailing us at ContactUs@trchealthcare.com.

The Strange Murders of the Wealthiest Murder Victims in History. Who killed the Billionaire Pharmaceutical CEO Barry and Honey Sherman? Why were their bodies placed in odd positions? Was a hitman hired by a Pharmaceutical company? To watch the podcast on YouTube: ⁠⁠⁠⁠⁠https://bit.ly/TheoriesOfTheThirdKindYT⁠⁠⁠⁠⁠ - Get instant access to 200+ bonus Audio episodes - Sign up here: ⁠⁠⁠⁠⁠https://theoriesofthethirdkind.supercast.com⁠ To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices

References NeuroMolecular Medicine2024. Volume 26,article 2.J of Neurochemistry 2018. V146, Issue4 August:416-428Rimsky-Korsikov. 1888. Scheherazade OP 35https://music.youtube.com/watch?v=zY4w4_W30aQ&si=9Q0bhwIdpY2aZ5yFAnderson, J. 1971 ".Your Move ". YEShttps://music.youtube.com/watch?v=WfgPEh2J9aI&si=QeKguSCVouRgjhR7

Tune in as Glenn Hunzinger, PwC's Health Industries Leader, connects with Matt Rich, PwC's Pharma and Life Sciences R&D Leader, to unpack the recent disruption at the FDA and what it means for the pharmaceutical and biotech sectors. They discuss how companies can stay agile in the face of regulatory uncertainty, avoid preventable delays, and take practical steps to move programs forward with clarity.Discussion highlights:Ongoing restructuring at the FDA is creating uncertainty and delays in drug and device approvals, with wide-ranging impacts across the pharma, biotech and medtech landscape.While companies can't control the regulatory environment, they can focus on improving internal speed, efficiency, and submission quality to keep programs moving forwardAvoiding preventable missteps, or “foot faults,” in data, endpoints, and submission packages is critical to reducing review delays and regulatory pushbackDiversifying risk by pursuing parallel regulatory pathways in other regions such as Europe and Japan can help accelerate access and reduce dependency on a single agencyIn the absence of a clear playbook, companies should focus on what they can control by applying past lessons, staying disciplined, and collaborating across the industry to support more efficient FDA review processesSpeakers:Matt Rich, PwC's Pharmaceutical and Life Sciences R&D LeaderGlenn Hunzinger, Partner, Health Industries Leader, PwCLinked materials:Navigating the FDA disruption: 4 key actions for pharmaFor more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.

Tune in as Glenn Hunzinger, PwC's Health Industries Leader and Roel van den Akker, PwC's Pharma and Life Sciences Deals Leader discuss the rapid rise of China's biotech industry and what it means for U.S. pharmaceutical companies. They discuss the evolving role of Chinese biotech in the global innovation landscape and share perspectives on how U.S. pharmaceutical companies can thoughtfully assess opportunities, manage cross-border complexities, and build effective partnering and diligence strategies.  Discussion highlights:China's biotech industry is growing fast and becoming a global player, with U.S. companies increasingly looking to partner with Chinese firms on cutting-edge scienceU.S. pharma leaders are encouraged to move beyond skepticism and stay curious by building relationships, learning from local innovation, and exploring new partnership opportunitiesSuccessfully partnering with Chinese biotech firms requires a careful and well-structured approach that accounts for global complexity, protects data and IP, and uses creative deal structures like new company formations to manage risk and stay flexibleU.S. companies need to be proactive in order to stay competitive by actively exploring global innovation, understanding the risks, and having a clear strategy to bring high-potential science to U.S. patientsSpeakers:Roel Van den Akker, Pharmaceutical and Life Sciences Deals Leader Glenn Hunzinger, Partner, Health Industries Leader, PwCLinked materials:China's rise as a biotech innovation hub: 4 key strategic questions for US biopharma executivesFor more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.

Rich welcomes Dr. Sebastian Gorka, deputy assistant to President Trump and senior director for counter terrorism at the National Security Council, to talk about the 'Golden Dome' defense system and other matters of national security. Next, Regeneron Pharmaceuticals is buying 23andMe for $256 million; we get reaction from Dr. Steven Quay, founder of Atossa Therapeutics. We also talk tariffs and China with Kerry Lutz, best-selling author of host of Financial Survival Network. Plus, Dr. Elaine Healy, whom you may recall as a COVID whistleblower, tells why she has informed Delaware authorities of the possible elder abuse of former President Joe Biden. Learn more about your ad choices. Visit podcastchoices.com/adchoices

On this episode, we pull on our lab coats for a chat with Colin MacKay, CEO and Founder of Symbiosis Pharmaceutical Services. Symbiosis is a specialist manufacturer of biopharmaceuticals for clients worldwide with an expertise that's globally recognised. We speak to Colin about the relentless incremental growth of Symbiosis, future expansion ambitions – and how Symbiosis negotiated symptomatic challenges of the COVID-19 pandemic and Brexit. What can your business learn from Symbiosis' journey? Join us to hear more.

Join Charles River experts Sandy Kimber, Charlotte Cumper, and Claire Richards from our Portishead site for a discussion on what makes some viruses more contagious than others, how viruses can trick your immune system, and how vaccines can affect viral spread.

Today, I am joined by Nisha Narang of Soulful Vegan and Leorah Clinical. Nisha is an experienced Pharmaceutical and Clinical Research Professional pioneering ethical innovation in healthcare development. With a Bachelor of .Pharmacy and Master of .Science. in Biochemical Pharmacology, Nisha has over 15 years of expertise in managing clinical research projects across regulatory guidelines and therapeutic areas.Her unique vision of combining scientific rigor with cruelty-free principles led to establishing Leorah Clinical, the world's first dedicated vegan-friendly clinical development consultancy. Through her leadership, Leorah Clinical helps companies develop innovative healthcare products that maintain excellence while adhering to ethical principles.Nisha's expertise spans clinical research and development, regulatory compliance, vegan-friendly innovation, and global project management, enabling Leorah Clinical to deliver comprehensive solutions that transform the future of healthcare development.In addition to her pioneering work at Leorah Clinical, Nisha is a passionate advocate for plant-based living. Through her coaching platform, Soulful Vegan, she empowers individuals to embrace a healthier lifestyle by offering personalized guidance on vegan nutrition and wellness. Her coaching sessions are rooted in compassion and tailored to help clients achieve their health goals while respecting their unique journeys.To connect with Nisha:For Vegan Product Development: Collaborate with Nisha to bring your cruelty-free product ideas to life. Book a consultation here- https://www.leorahclinical.com/consultation/For Science-Based Vegan Health Coaching: Start your journey toward optimal health with personalized coaching plans. Choose a plan that works for you here- https://soulfulvegan.com.au/coaching/To connect with me:Follow me on Facebook and Instagram @didyoubringthehummusFor more info on my Public Speaking 101 program: ⁠https://www.didyoubringthehummus.com/publicspeakingforactivists⁠Contact me here or send me an email at info@didyoubringthehummus.comSign up for meditation sessions hereSign up for The Vegan Voyage, to sponsor the podcast, book meditations packages, or sign up for my Public Speaking program hereJoin my Podcast Fan Facebook Group: https://www.facebook.com/groups/didyoubringthehummus/To be a guest on the podcast: https://www.didyoubringthehummus.com/beaguest©2025 Kimberly Winters - Did You Bring the Hummus LLCTheme Song ©2020 JP Winters ⁠@musicbyjpw⁠

In this episode, I sit down with Shay Domangue, PA-C, whose career path took a bold and inspiring turn — from hospitalist PA/ internal medicine to building her own social media business in elder care to transitioning to marketing development in the pharmaceutical device industry. She's now the Gulf Coast Field Market Development Specialist in the Renal Denervation business unit for Medtronic and is also raising two little humans (with her husband's help).Shay shares what it was like to reach a breaking point in clinical medicine and how listening to that inner voice led her to explore something new. She didn't just walk away — she walked toward a more aligned, values-based life and career.We talk about the early days of entrepreneurship, the emotional and logistical challenges of building something from scratch, and the surprising role that networking played in her transition into the pharmaceutical industry.Shay opens up about redefining success, protecting her energy, and how work-life balance has become a non-negotiable in her new chapter. She also drops some hard-earned wisdom for clinicians who are feeling stuck or wondering what else is out there — especially if you've ever thought, “I can't do this for 20 more years.”This conversation is for you if you're craving purpose, dreaming of flexibility, or just want to hear from someone who's made a major pivot and lived to tell the tale.CONNECT WITH SHAY:Linkedin.com/in/shaydomangueShay's polypharmacy info on TikTok: @elder.care.hubHOPE'S BOOK:⁠⁠Healing Clinician Burnout, How to Revive Your Life and Career ⁠⁠(available in ebook and paperback)CONNECT AND SIGN UP FOR COACHING:⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Hope's Website: www.coachhopecook.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Hope's IG @coachhopecook⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Hope's FB @hopeallencook⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Hope's LinkedIn: hope-cook-56041283/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Hope's YouTube @coachhopecook⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Email: hope.cook@gmail.comLove y'all, and remember: There's always hope!

I briefly discuss how the pharmaceutical collapse and price reduction, along with global deals and alliances that are being made are all a part of the plan.  I also discuss child exploitation, the role of schools; and more jab revelations along with the elimination of Fluoride in Florida drinking water.   Book Websites: https://www.moneytreepublishing.com/shop PROMO CODE: “AEFM” for 10% OFF https://armreg.co.uk  PROMO CODE: "americaneducationfm" for 15% off all books and products.  (I receive no kickbacks).

051325 Scott Adams Show, Trump Pharmaceutical EO, Trump in Riyadh, Democrats in Chaos

Critical minerals are required for the manufacturing of electronics, aerospace equipment, medical devices, and renewable energy technologies, making them essential for a country's economic and national security. These materials have been at the center of China's domestic and foreign policy for many decades, and China's ability to integrate internal industrial policies with foreign trade and investment policies has allowed them to gain dominance in the market. Meanwhile, the US has lagged behind China in terms of both access to and processing technology of critical minerals. The country has been heavily dependent on China for its critical minerals and struggles to find an alternative supplier.China's announcement to impose export restrictions on seven rare earth elements on April 4th has opened many conversations surrounding critical minerals, especially regarding the US and its supply chain vulnerabilities. What has China done to achieve their global dominance in the critical minerals sector, and what can the US do to address the overdependence issue they are facing today? To answer these questions and more, host Bonnie Glaser is joined by Gracelin Baskaran, the director of the Critical Minerals Security Program at the Center for Strategic and International Studies. She is a mining economist whose area of expertise is critical minerals and trade. Timestamps[00:00] Start[02:13] US Dependencies on Rare Earths and Critical Minerals[03:51] Sourcing from Latin America, Africa, and Asia[06:28] Environmental Harm from Mining and Processing[08:11] Deliberate Suppression of the Price of Rare Earths in the Market[11:06] Chinese Exports Restrictions on Seven Rare Earth Elements[14:08] US Administrations' Approaches to Critical Minerals Vulnerability[20:02] 2010 Fishing Boat Accident and Japan's Response [24:00] What might China do moving forward? [27:42] Timeframe for the US to Catch Up to China

- Broadcast News Introduction and Upcoming Segments (0:00) - AI Advancements and Their Impact on Jobs (0:45) - Breaking News: Trump-China Trade Deal and Its Implications (2:46) - Pakistan-India Cyber War and Its Potential Escalation (9:55) - Power Grid Vulnerabilities and Preparedness (13:36) - Crypto Wallets and the Importance of Self-Custody (19:04) - AI Capabilities and Their Implications for Human Jobs (25:14) - The Role of Enoch AI in Empowering Users (59:30) - The War on Human Cognition and Its Vectors (1:05:29) - Strategies for Protecting Cognitive Function (1:21:34) - Chemotherapy and Cognitive Impairment (1:21:56) - Natural Light and Sun Exposure (1:25:06) - Media and Information Warfare (1:30:33) - Societal and Behavioral Factors (1:33:37) - Defending Against Environmental Toxins (1:41:05) - Nutritional and Dietary Factors (1:47:00) - Pharmaceutical and Medical Warfare (1:49:22) - EMF Exposure and Technological Risks (1:59:51) - Information Warfare and Censorship (2:02:12) - Societal and Behavioral Factors (2:11:11) - Zionist and Chinese Strategic Moves in the Middle East (2:25:45) - Trump's Arrogance and Military Presence in Panama (2:26:04) - China's Influence and Economic Strategy in Panama (2:26:21) - Strategic Importance of the Panama Canal (2:52:23) - Strait of Hormuz and Global Energy Supply (3:06:20) - US-China Trade War and Economic Implications (3:14:03) - Anthropological Warfare and Cultural Resilience (3:14:21) - Migration and Demographic Warfare (3:22:15) - Global Economic and Political Dynamics (3:28:51) - Future Strategic Moves and Predictions (3:33:17) For more updates, visit: http://www.brighteon.com/channel/hrreport NaturalNews videos would not be possible without you, as always we remain passionately dedicated to our mission of educating people all over the world on the subject of natural healing remedies and personal liberty (food freedom, medical freedom, the freedom of speech, etc.). Together, we're helping create a better world, with more honest food labeling, reduced chemical contamination, the avoidance of toxic heavy metals and vastly increased scientific transparency. ▶️ Every dollar you spend at the Health Ranger Store goes toward helping us achieve important science and content goals for humanity: https://www.healthrangerstore.com/ ▶️ Sign Up For Our Newsletter: https://www.naturalnews.com/Readerregistration.html ▶️ Brighteon: https://www.brighteon.com/channels/hrreport ▶️ Join Our Social Network: https://brighteon.social/@HealthRanger ▶️ Check In Stock Products at: https://PrepWithMike.com

We kick-off the week with a LIVE press conference from President Trump on a new proposal by the administration to lower drug prices, news on tariffs/China, and a preview of a pivotal case sitting before the Supreme Court. Plus ~ important context to a now viral exchange between the Department of Homeland Security Secretary and Senator Van Hollen (D-MD) over the fate of Kilmar Abrego Garcia.  SUPPORT OUR MISSION: Love nonpartisan news? Want a bigger serving of the serious headlines?  Here's how you can become a SCOOP insider: https://www.scoop.smarthernews.com/get-the-inside-scoop/    Shop our gear!  Instagram: https://www.instagram.com/smarthernews/  Website: https://smarthernews.com/  YouTube Channel: https://www.youtube.com/smarthernews 

Podcast: Government Information Security Podcast (LS 27 · TOP 10% what is this?)Episode: Mature But Vulnerable: Pharmaceutical Sector's Cyber RealityPub date: 2025-05-09Get Podcast Transcript →powered by Listen411 - fast audio-to-text and summarizationPharmaceutical companies typically have more mature cyber programs than other healthcare factions, but these firms also face unique risks involving their large attack surfaces, complex manufacturing, supply chains and sensitive intellectual property, said Joshua Mullen of Booz Allen Hamilton.The podcast and artwork embedded on this page are from GovInfoSecurity.com, which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.

This podcast was created using Notebook LM.Based on a new study, a recent article highlights the potential of non-pharmaceutical interventions for managing chronic pain, offering alternatives or complements to medication. 

Gemma started her career studying Mechanical Engineering at Cardiff University. She quickly discovered the world of Continuous Improvement and spent 20 years working to improve processes and systems within various manufacturing industries including Automotive, Pharmaceutical, Dairy, Cosmetics & Toiletries, Food, and Medical Devices. She has been a CI Manager numerous times and an Operations Manager running a factory of over 500 people.Gemma is hugely passionate about Improvement and developing people and processes. She gets such a kick out of coaching and facilitating, especially when she sees the lightbulb switch on in someone's head – when they solve a problem; when they realize they have the power to change; or when they get excited about all the improvements they could make.In 2019, Gemma left the world of employment to establish her own business, SPARK Improvement, aiming to switch on as many lightbulbs as possible. Her mission is to help organizations and individuals be the BEST they can be, by helping people SEE, helping people THINK, and helping people CHANGE.Gemma is based in Cheshire in the UK, working globally.Link to claim CME credit: https://www.surveymonkey.com/r/3DXCFW3CME credit is available for up to 3 years after the stated release dateContact CEOD@bmhcc.org if you have any questions about claiming credit.

Encouraging physicians to make a diagnosis of irritable bowel syndrome and prescribe medication for it is big business. I'm not saying that medication for IBS is never a good idea or never effective, but I am saying that it is often an overly expedient solution that doesn't usually lead to lasting relief for the simple reason that IBS consists of multiple different conditions. Since there is no one unifying diagnosis of "IBS" there can't be one unifying pharmaceutical solution. We'd love to hear from you - send us a text!Thank you for being a part of our community! For the latest in digestive wellness go to https://gutbliss.com and follow us on https://www.instagram.com/gutbliss/ for more gut health info. Dr. Robynne Chutkan

We take a deep dive into the lesser-known industry of “pharmacy benefits managers” (PBMs) which are parasitical companies that sit in the middle of the incredibly consolidated and vertically integrated market of pharmaceuticals hospitals insurers pharmacy benefits managers pharmacies. Through the simple administrative business of making lists of drugs and networks of pharmacies, PBMs have managed to carve out a multi-billion dollar rent-seeking industry premised on controlling (and jacking up) how much drugs cost and where you can get them—and extracting as much money as possible from people who need those drugs. ••• Timeline of FTC lawsuit against PBMs and relevant documents: https://www.ftc.gov/legal-library/browse/cases-proceedings/221-0114-caremark-rx-zinc-health-services-et-al-matter-insulin ••• Concurring Statement of Commissioner Andrew N. Ferguson https://www.ftc.gov/system/files/ftc_gov/pdf/Ferguson-Statement-Pharmacy-Benefit-Managers-Report.pdf ••• Market Power and Inequality: The Antitrust Counterrevolution and Its Discontents | Lina Khan and Sandeep Vaheesan https://scholarship.law.columbia.edu/faculty_scholarship/2790/ ••• Inside the Mafia of Pharma Pricing | Matt Stoller https://www.thebignewsletter.com/p/inside-the-mafia-of-pharma-pricing ••• A brief look at current debates about pharmacy benefit managers https://www.brookings.edu/articles/a-brief-look-at-current-debates-about-pharmacy-benefit-managers/ Standing Plugs: ••• Order Jathan's new book: https://www.ucpress.edu/book/9780520398078/the-mechanic-and-the-luddite ••• Subscribe to Ed's substack: https://substack.com/@thetechbubble ••• Subscribe to TMK on patreon for premium episodes: https://www.patreon.com/thismachinekills Hosted by Jathan Sadowski (bsky.app/profile/jathansadowski.com) and Edward Ongweso Jr. (www.x.com/bigblackjacobin). Production / Music by Jereme Brown (bsky.app/profile/jebr.bsky.social)

When Luke Rosen's daughter was diagnosed with KIF1A—a rare, progressive neurological disorder—he didn't wait for answers. He and his wife built a community, launched a nonprofit, and became a driving force in rare disease research. In this episode, Luke shares how patient-led science accelerates treatments and reshapes what's possible for families like his. Show Notes  Sounds of Science - N=1 Episode Charles River | Rare Disease Charles River | Rare Disease for Drug Discovery Charles River | ASO Screening Services Personalized ASO Provides Improvement for a Girl with KAND< an Ultra-rare Disease SCA3: A Family Affair Susannah's Superhero Story 

On this episode of The Medical Alley Podcast, we have a conversation with Courtney Jones, Director of Commercial Development at Nu-Tek BioSciences.As the only completely animal-free peptone manufacturing site in the United States, Nu-Tek BioSciences is paving the way for sustainable and effective drug development. Courtney dives into the work Nu-Tek BioSciences is doing, its new manufacturing facility in Austin, MN, and the future of innovation in the biotech space.Send us a message! Follow Medical Alley on social media on LinkedIn, Facebook, X and Instagram.

Plus, South Korea says it's preparing roughly $23 billion in government support for the chip sector amid tariff uncertainty. And Netflix aims for a $1trillion market capitalization. Luke Vargas hosts. Sign up for WSJ's free What's News newsletter. Learn more about your ad choices. Visit megaphone.fm/adchoices

Episode 2630: Vinnie Tortorich speaks to Dr. Anthony Jay and they discuss items from plastics to genetics, misrepresentation in the media, and more. https://vinnietortorich.com/2025/04/from-plastics-to-genetics-dr-anthony-jay-episode-2630 PLEASE SUPPORT OUR SPONSORS YOU CAN WATCH ALL THE PODCAST EPISODES ON YOUTUBE -  From Plastics to Genetics Dr. Anthony Jay was first on Fitness Confidential back in 2017. (2:00) His book can be purchased in Vinnie's Book Club: Estrogeneration: How Estrogenics Are Making You Fat, Sick, and Infertile (Chagrin and Tonic Series)   He is a researcher and geneticist and the information he wrote in the book is finally being discussed on a larger scale. BPAs don't always mean less harmful; BPS, phthalates, and other chemicals are substituted and can still be an issue. (5:30) The United States allows materials in products and food that are banned in Europe. (8:00) Pharmaceutical companies don't have to release studies, and what they do release is often cherry-picked data presented to the media. Burning carbs for energy means autophagy is not happening. (18:00) Health and genetics play a part in an individual's response to a virus. (23:30) Dr. Jay is a genetic researcher and consultant who helps people pinpoint possible genetic origins of health issues and helps them make changes based on data. They discuss the progression of COVID-19 and the mandates that came along with it. (31:00) The media and pharmaceutical corporations often use fear-mongering tactics and mishandle information. (40:00) Hope and Possibilities Anthony is hopeful that RFK, Jr. will make improvements in the health system, like getting crap out of infant formula. (47:15) What is Dr. Jay's opinion on raw milk? (51:30) Some people are highly sensitive to dairy and generally need to stay away from all dairy; however, others can have raw dairy and not have an issue. Between raw and pasteurized, Anthony personally prefers raw milk and he sources it from a local dairy that he trusts. Conventional milk can have emulsifiers in it to keep it from separating, but emulsifiers are horrible for your health. Emulsifiers are tasteless detergents that weaken your gut lining. (57:30) 23andMe and DNA testing. (1:00:00) Dr Jay is a genetic consultant who can help you see what health needs you may have. (1:00:00) If you decide to use the services that analyze your DNA, you can often opt out of sharing your information. Dr. Jay can give you health insights consultation based on your genetic data. You can do so by contacting him through his website. If you have used a service like 23andMe, Ancestry, MyHeritage, or SelfDecode, and have access to your raw data file, he will be able to help. More News If you are interested in the NSNG® VIP group, closed for registration, but you can get on the wait list - Don't forget to check out Serena Scott Thomas on Days Of Our Lives on the Peacock channel.  “Dirty Keto” is available on Amazon! You can purchase or rent it . Make sure you watch, rate, and review it! Eat Happy Italian, Anna's next cookbook is available!  You can go to  You can order it from .  Anna's recipes are in her cookbooks, website, and Substack–they will spice up your day!  Don't forget you can invest in Anna's Eat Happy Kitchen through StartEngine.  Details are at Eat Happy Kitchen.  There's a new NSNG® Foods promo code you can use! The promo code ONLY works on the NSNG® Foods website, NOT on Amazon. https://nsngfoods.com/   PURCHASE  DIRTY KETO (2024) The documentary launched in August 2024! Order it TODAY! This is Vinnie's fourth documentary in just over five years. Visit my new Documentaries HQ to find my films everywhere:  Then, please share my fact-based, health-focused documentary series with your friends and family. Additionally, the more views, the better it ranks, so please watch it again with a new friend! REVIEWS: Please submit your REVIEW after you watch my films. Your positive REVIEW does matter! PURCHASE BEYOND IMPOSSIBLE (2022) Visit my new Documentaries HQ to find my films everywhere:  REVIEWS: Please submit your REVIEW after you watch my films. Your positive REVIEW does matter! FAT: A DOCUMENTARY 2 (2021) Visit my new Documentaries HQ to find my films everywhere:  FAT: A DOCUMENTARY (2019) Visit my new Documentaries HQ to find my films everywhere: 

00:00:00 - Bizarre Manager Tales and Alex Jones Clips Show opens with banter about Joe's intense management style and new gig. A selection of wild Alex Jones clips is played, prompting commentary on his chaotic delivery. Brief update on financial markets and some humorous talk about waffles and economic indicators. 00:10:00 - Trump's Tariffs and Global Trade Drama Trump enacts 125% tariffs on China, sparing other nations temporarily. Discussion on whether the goal is to isolate China or encourage wider global cooperation. Kevin O'Leary's call for 400% tariffs sparks debate about fairness and enforcement. 00:20:00 - China Retaliates and Trade War Escalates China responds with 84% retaliatory tariffs, calling for global unity against Trump. Memes and viral videos mocking American factory jobs are discussed. Hosts defend blue-collar work and examine why jobs were offshored post-NAFTA. 00:30:00 - Political Rage and Brain Circuitry New study links political extremism to specific brain circuits. Hosts joke about future pharmaceuticals to dull political emotions, like a “political Prozac.” Pharmaceutical industry's potential to profit off this condition is debated. 00:40:00 - CE-5 UFO Summoning and Sky Jellyfish Jake Barbour's team claims to psychically summon UFOs using CE-5 protocols. Descriptions of “Class 7” jellyfish-like UFOs that pulse and float intelligently. Mick West's debunking dismissed, with debate on whether these are balloons or something more. 00:50:00 - New Jersey Drone Mystery and FAA Denials Claims of anomalous drone behavior over New Jersey in December 2024. FAA reportedly unaware of or uninvolved in some sightings, raising suspicions. Speculation of government cover-ups and comparisons to historic UAP sightings. 01:00:00 - Restaurant Scammers and Ark Excavation Father and son duo scam over 100 French restaurants using fake card/ID trick. Scheme included pretending cards didn't work and leaving IDs they later replaced. Quick note that another attempt is underway to dig up Noah's Ark. 01:10:00 - Disturbing Teacher Abuse and Funeral Fails Shocking story of a teacher inappropriately involved with a special-needs student, also involving drugs and a murder plot. Shift to humorous but unfortunate funeral accident where pallbearers fall into a grave. Referenced comedy sketch “Coffin Flop” adds levity to an awkward moment. 01:20:00 - Middle-Aged Men Trading Cards in Japan Japanese trading card craze features real-life elderly men as collectible characters. Discussion on creating an American version featuring “Ohio Man” and regional archetypes. Hosts express genuine excitement and support for the quirky collectible concept. 01:30:00 - Urine Revenge and Tech Troubles A man throws bottles of urine at a business that denied him a job interview. Mike vents frustration about TeeSpring withholding merch funds, delaying tech upgrades. Conversation shifts toward moving to a new platform for merchandise fulfillment. 01:40:00 - Pee Tossing Fallout and David Paulides Kickstarter Extended jokes about urine-throwing suspect and weird job interview tactics. Update on David Paulides' successful Kickstarter for a new Missing 411 film. Mike reveals he won't receive his merch funds in time to upgrade his gear due to delays from TeeSpring. 01:50:00 - Mac Mini Upgrades and Japanese Card Economics Mike talks about upgrading his studio with a new Mac Mini to support soundboards. More commentary on Japanese middle-aged trading cards, including pricing, popularity, and potential U.S. parallels. Hosts suggest capitalizing on the trend with an American version featuring local archetypes.   Copyright Disclaimer Under Section 107 of the Copyright Act 1976, allowance is made for "fair use" for purposes such as criticism, comment, news reporting, teaching, scholarship, and research ▀▄▀▄▀ CONTACT LINKS ▀▄▀▄▀ ► Phone: 614-388-9109 ► Skype: ourbigdumbmouth ► Website: http://obdmpod.com ► Twitch: https://www.twitch.tv/obdmpod ► Full Videos at Odysee: https://odysee.com/@obdm:0 ► Twitter: https://twitter.com/obdmpod ► Instagram: obdmpod ► Email: ourbigdumbmouth at gmail ► RSS: http://ourbigdumbmouth.libsyn.com/rss ► iTunes: https://itunes.apple.com/us/podcast/our-big-dumb-mouth/id261189509?mt=2   - Affiliates Links - Jackery:  https://shrsl.com/3cxhf Barebones:  https://bit.ly/3G38773  Buy Tea! Mike's wife makes some good tea: Naked Gardener Teas: https://www.thenakedgardener.us/store Bags Art Store: https://www.redbubble.com/people/BagsDraws/  

The Rich Zeoli Show- Hour 4: 6:05pm- Stacy Garrity—Pennsylvania Treasurer—joins The Rich Zeoli Show to discuss her new “Money Match” initiative which will automatically return unclaimed properties to thousands of Pennsylvanians. The checks total $1.7 million and are being mailed to an estimated 7,000+ PA residents. 6:30pm- According to what appears to be an erroneous report, Health and Human Services Secretary Robert F. Kennedy Jr. planned to ban pharmaceutical advertisements on television. Rich explains why this would be a bad idea—and likely a First Amendment violation. 6:40pm- On Tuesday, DNI Director Tulsi Gabbard, FBI Director Kash Patel, and CIA Director John Ratcliffe appeared before the Senate Intelligence Committee. During one notable exchange, Sen. Angus King (I-ME) bizarrely scolded Director Gabbard for removing climate change from a list of the most dangerous global threats. 6:50pm- During a Human Rights Campaign event, Congresswoman Jasmine Crockett (D-TX) referred to Texas Governor Greg Abbott as “governor hot wheels.” Gov. Abbott has used a wheelchair since an accident in 1984.